Novel Therapeutic Approaches for Colorectal Cancer Treatment
Athanasios G Papavassiliou1, Donatella Delle Cave2
1Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
International Journal of Molecular Sciences
|February 24, 2024
Summary
Colorectal cancer (CRC) is a major global health challenge, ranking as the third most common and second deadliest malignancy worldwide. Understanding CRC epidemiology is crucial for effective prevention and treatment strategies.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Colorectal cancer (CRC) is a significant global health burden, identified as the third most frequently diagnosed cancer and the second leading cause of cancer-related mortality worldwide, according to GLOBOCAN 2020 data.
- The high incidence and mortality rates underscore the urgent need for comprehensive strategies to combat CRC.
- Understanding the global epidemiological landscape of CRC is essential for resource allocation and targeted interventions.
Discussion:
- The GLOBOCAN 2020 data provides a critical overview of the worldwide burden of colorectal cancer.
- Analysis of these statistics is vital for identifying high-risk populations and geographical areas.
- This data serves as a foundation for developing and refining global strategies against CRC.
Key Insights:
- Colorectal cancer (CRC) ranks as the third most common cancer globally.
- CRC is the second leading cause of cancer death worldwide.
- The GLOBOCAN 2020 data highlights the substantial and ongoing impact of CRC on global health.
Outlook:
- Continued monitoring of CRC incidence and mortality trends is essential.
- Further research into the etiological factors and disparities in CRC is warranted.
- Global collaboration is key to reducing the burden of colorectal cancer through improved prevention, early detection, and treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127